These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
212 related items for PubMed ID: 1799168
1. Lymphocyte subsets in patients with idiopathic thrombocytopenic purpura during high-dose gamma globulin therapy. Pogliani EM, Della Volpe A, Casaroli I, Maffe PF, Corneo G. Allergol Immunopathol (Madr); 1991; 19(3):113-6. PubMed ID: 1799168 [Abstract] [Full Text] [Related]
2. Alteration of T cell subsets and immunoglobulin synthesis in vitro during high dose gamma-globulin therapy in patients with idiopathic thrombocytopenic purpura. Tsubakio T, Kurata Y, Katagiri S, Kanakura Y, Tamaki T, Kuyama J, Kanayama Y, Yonezawa T, Tarui S. Clin Exp Immunol; 1983 Sep; 53(3):697-702. PubMed ID: 6193913 [Abstract] [Full Text] [Related]
4. Autoimmune thrombocytopenia following peripheral blood stem cell autografting. Ashihara E, Shimazaki C, Hirata T, Okawa K, Oku N, Goto H, Inaba T, Fujita N, Nakagawa M. Bone Marrow Transplant; 1993 Sep; 12(3):297-9. PubMed ID: 7902157 [Abstract] [Full Text] [Related]
5. Prednisone versus deflazacort in the treatment of autoimmune thrombocytopenic purpura: evaluation of clinical response and immunological modifications. Ferrari A, Pasqualetti D, Del Bianco P, Gandolfo GM, Chistolini A, Mazzucconi MG. Haematologica; 1991 Sep; 76(4):342-5. PubMed ID: 1794742 [Abstract] [Full Text] [Related]
7. Serum leptin levels in patients with idiopathic thrombocytopenic purpura. Zhan M, Zhao H, Yang R, Han ZC. Eur J Haematol; 2004 May; 72(5):348-52. PubMed ID: 15059070 [Abstract] [Full Text] [Related]
8. [The clinical significance of immune-related marker detection in idiopathic thrombocytopenic purpura]. Chen JF, Yang LH, Feng JJ, Chang LX, Liu XE, Lu YJ. Zhonghua Nei Ke Za Zhi; 2010 Sep; 49(9):765-8. PubMed ID: 21092448 [Abstract] [Full Text] [Related]
9. Danazol therapy in idiopathic thrombocytopenic purpura: the efficacy of low-medium dose therapy. Kondo H, Iseki T, Goto S, Takaso T, Ohto M, Okuda K. Int J Hematol; 1992 Jun; 55(3):293-300. PubMed ID: 1498320 [Abstract] [Full Text] [Related]
10. Current options for the treatment of idiopathic thrombocytopenic purpura. Arnold DM, Kelton JG. Semin Hematol; 2007 Oct; 44(4 Suppl 5):S12-23. PubMed ID: 18096468 [Abstract] [Full Text] [Related]
11. First-line therapies for immune thrombocytopenic purpura: re-evaluating the need to treat. Rodeghiero F. Eur J Haematol Suppl; 2008 Feb; (69):19-26. PubMed ID: 18211569 [Abstract] [Full Text] [Related]
12. [Infection-induced transient increase in the platelet count, and a transient remission of thrombocytopenia with high-dose intravenous gammaglobulin therapy during intercurrent pneumonia in chronic idiopathic thrombocytopenic purpura]. Katoh M, Ishikawa I, Umeda M, Tsukahara T. Rinsho Ketsueki; 1994 Mar; 35(3):296-9. PubMed ID: 8158852 [Abstract] [Full Text] [Related]
13. Chronic idiopathic thrombocytopenic purpura (ITP): molecular mechanisms and implications for therapy. Andersson PO, Wadenvik H. Expert Rev Mol Med; 2004 Nov 09; 6(24):1-17. PubMed ID: 15538954 [Abstract] [Full Text] [Related]
14. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders. Clofent-Sanchez G, Laroche-Trainean J, Lucas S, Rispal P, Pellegrin JL, Nurden P, Nurden A. Hum Antibodies; 1997 Nov 09; 8(2):50-9. PubMed ID: 9289388 [Abstract] [Full Text] [Related]
15. In-vitro inhibition of antiplatelet autoantibodies by intravenous immunoglobulins and Rh immunoglobulins. Mehta YS, Badakere SS. J Postgrad Med; 1996 Nov 09; 42(2):46-9. PubMed ID: 9715299 [Abstract] [Full Text] [Related]
16. Leptin enhances in vitro secretion of IgG antiplatelet antibodies by splenocytes and peripheral blood mononuclear cells from patients with chronic idiopathic thrombocytopenic purpura. Ren H, Zhao H, Wang T, Yang Y, Han Z, Liu B, Wu Z, Tao J, Zhou B, Zhang L, Yang R, Han ZC. Clin Immunol; 2006 Aug 09; 120(2):205-11. PubMed ID: 16774845 [Abstract] [Full Text] [Related]
17. Does H. Pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases? Gasbarrini A, Franceschi F. Am J Gastroenterol; 2005 Jun 09; 100(6):1271-3. PubMed ID: 15929756 [Abstract] [Full Text] [Related]
18. Efficacy, safety, and dose response of intravenous anti-D immune globulin (WinRho SDF) for the treatment of idiopathic thrombocytopenic purpura in children. Freiberg A, Mauger D. Semin Hematol; 1998 Jan 09; 35(1 Suppl 1):23-7. PubMed ID: 9523746 [Abstract] [Full Text] [Related]
19. Clinical efficacy and safety of Flebogammadif, a new high-purity human intravenous immunoglobulin, in adult patients with chronic idiopathic thrombocytopenic purpura. Julia A, Kovaleva L, Loria S, Alberca I, Hernandez F, Sandoval V, Sierra J, Vidaller A, Ayguasanosa J, Carretero M. Transfus Med; 2009 Oct 09; 19(5):260-8. PubMed ID: 19747289 [Abstract] [Full Text] [Related]
20. Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab. Schweizer C, Reu FJ, Ho AD, Hensel M. Ann Hematol; 2007 Oct 09; 86(10):711-7. PubMed ID: 17622529 [Abstract] [Full Text] [Related] Page: [Next] [New Search]